Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Conti

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Current Drug Metabolism|October 16, 2015
Metabolic Alterations in Renal and Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Critical Reviews in Oncology/Hematology|June 14, 2015
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Kalliopi Andrikou, et al.
Urologic Oncology|July 30, 2014
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinomaDaniele Minardi, Matteo Santoni, Guendalina Lucarini, et al.
Future Science OA|December 30, 2016
Role of STAT3 pathway in genitourinary tumorsMatteo Santoni, Alessandro Conti, Francesco Piva, et al.
The Journal of Surgical Research|June 28, 2011
Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stentDaniele Minardi, Oscar Cirioni, Roberto Ghiselli, et al.
Future Oncology (London, England)|March 26, 2015
Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analysesKalliopi Andrikou, Matteo Santoni, Francesco Piva, et al.
Anticancer Research|January 1, 2015
Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expressionDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Cancer Treatment Reviews|June 4, 2015
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trialsChiara Ciccarese, Francesco Massari, Matteo Santoni, et al.
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Clinical Genitourinary Cancer|December 4, 2014
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancerMatteo Santoni, Simon J Crabb, Alessandro Conti, et al.
Current Drug Metabolism|October 16, 2015
Metabolic Alterations in Renal and Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Critical Reviews in Oncology/Hematology|June 14, 2015
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Kalliopi Andrikou, et al.
Urologic Oncology|July 30, 2014
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinomaDaniele Minardi, Matteo Santoni, Guendalina Lucarini, et al.
Future Science OA|December 30, 2016
Role of STAT3 pathway in genitourinary tumorsMatteo Santoni, Alessandro Conti, Francesco Piva, et al.
The Journal of Surgical Research|June 28, 2011
Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stentDaniele Minardi, Oscar Cirioni, Roberto Ghiselli, et al.
Future Oncology (London, England)|March 26, 2015
Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analysesKalliopi Andrikou, Matteo Santoni, Francesco Piva, et al.
Anticancer Research|January 1, 2015
Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expressionDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Cancer Treatment Reviews|June 4, 2015
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trialsChiara Ciccarese, Francesco Massari, Matteo Santoni, et al.
Annals of Surgical Oncology|September 20, 2014
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancerLorena Rossi, Matteo Santoni, Simon J Crabb, et al.
Pageof 8